Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lieberman

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
Brain Research|March 17, 2001
Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptorsS Miyamoto, R B Mailman, J A Lieberman, et al.
Brain Research|October 21, 1999
Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamineG E Duncan, S Miyamoto, J N Leipzig, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2000
Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving miceS Miyamoto, J N Leipzig, J A Lieberman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolismG E Duncan, S Miyamoto, J N Leipzig, et al.
Biological Psychiatry|April 15, 1996
Premature disinhibition of P3 generation in schizophreniaA M Shelley, S Grochowski, J A Lieberman, et al.
Lancet (London, England)|May 23, 1992
Rechallenge in clozapine-induced agranulocytosisA Z Safferman, J A Lieberman, J M Alvir, et al.
Biological Psychiatry|April 1, 1992
Clozapine and akathisiaA Z Safferman, J A Lieberman, S Pollack, et al.
Lancet (London, England)|May 12, 1984
Antibodies to acetylcholine receptors in tardive dyskinesiaJ A Lieberman, R J Bradley, M Rubinstein, et al.
Journal of Clinical Psychopharmacology|October 1, 1995
Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot studyL A Linday, C E Pippenger, A Howard, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
Brain Research|March 17, 2001
Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptorsS Miyamoto, R B Mailman, J A Lieberman, et al.
Brain Research|October 21, 1999
Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamineG E Duncan, S Miyamoto, J N Leipzig, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2000
Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving miceS Miyamoto, J N Leipzig, J A Lieberman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolismG E Duncan, S Miyamoto, J N Leipzig, et al.
Biological Psychiatry|April 15, 1996
Premature disinhibition of P3 generation in schizophreniaA M Shelley, S Grochowski, J A Lieberman, et al.
Lancet (London, England)|May 23, 1992
Rechallenge in clozapine-induced agranulocytosisA Z Safferman, J A Lieberman, J M Alvir, et al.
Biological Psychiatry|April 1, 1992
Clozapine and akathisiaA Z Safferman, J A Lieberman, S Pollack, et al.
Lancet (London, England)|May 12, 1984
Antibodies to acetylcholine receptors in tardive dyskinesiaJ A Lieberman, R J Bradley, M Rubinstein, et al.
Journal of Clinical Psychopharmacology|October 1, 1995
Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot studyL A Linday, C E Pippenger, A Howard, et al.
Pageof 25